Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs Palatin Technologies
Over the past year CLRB returned −64.9% and PTN returned −50.0%; their daily moves had a correlation of 0.05.
CLRB −64.9% PTN −50.0%Growth of $1, one year, split-adjusted
| Metric | CLRB | PTN |
|---|---|---|
| Price | $1.23 | $5.52 |
| Market cap | $11.6M | $9.8M |
| Today | +9.82% | −7.85% |
| 1 month | −47.7% | −46.0% |
| 6 months | −56.7% | −74.7% |
| Year to date | −58.3% | −64.1% |
| 1 year | −72.7% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −1449.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.7× |
| Net cash | $34.0M | $7.5M |
| Dividend yield | — | — |
| Volatility (60d) | 64.2% | 108.0% |
| Short % of float | 1.9% | 22.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).